MiR-429 Determines Poor Outcome and Inhibits Pancreatic Ductal Adenocarcinoma Growth by Targeting TBK1 | Zendy

Bin Song | Zendy; Kailian Zheng | Zendy; Hongyun Ma | Zendy; An-An Liu | Zendy; Wei Jing | Zendy; Chenghao Shao | Zendy; Gang Li | Zendy; Gang Jin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

MiR-429 Determines Poor Outcome and Inhibits Pancreatic Ductal Adenocarcinoma Growth by Targeting TBK1

Author(s) -

Bin Song,

Kailian Zheng,

Hongyun Ma,

An-An Liu,

Wei Jing,

Chenghao Shao,

Gang Li,

Gang Jin

Publication year - 2015

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000373995

Subject(s) - cancer research , microrna , cell growth , pancreatic cancer , biology , cell culture , cancer , medicine , gene , genetics

Pancreatic ductal adenocarcinoma (PDAC) ranks fourth on the list of cancer-related causes of death and its prognosis has not improved significantly over the past decades. Deregulation or dysfunction of miRNAs contribute to cancer development. Previous data indicates that miR-429 is involved in the pathogenesis of PDAC. However, the role of miR-429 in PDAC remained unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research